SCHEMBL22010398

SCHEMBL22010398

N/N=C(/SCC(N)=O)N(N)c1ccc(C(=O)O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 2/20 0.38
▸ CA12 O43570 6/20 0.36
▸ CA2 P00918 6/20 0.36
▸ CA9 Q16790 6/20 0.36
▸ CA1 P00915 5/20 0.36
▸ F2 P00734 3/20 0.36
▸ PRSS1 P07477 3/20 0.36
▸ PRSS2 P07478 3/20 0.36
▸ PRSS3 P35030 3/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ TP53 P04637 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ CA14 Q9ULX7 4/20 0.33
▸ CA3 P07451 3/20 0.33
▸ CA6 P23280 3/20 0.33
▸ CA5A P35218 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22009370 0.89 HDAC3 (0.39) NOS1CA12CA2CA9CA1
SCHEMBL24019799 0.87 KMT2A (0.38) NOS1CA12CA2CA9CA1
SCHEMBL22010009 0.87 PARP15 (0.38) NOS1CA12CA2CA9CA1
SCHEMBL22009385 0.83 HDAC3 (0.51) CA12CA2CA9CA1KMT2A
SCHEMBL22009698 0.83 HDAC3 (0.37) NOS1KMT2AMEN1NPC1POLB
SCHEMBL22009338 0.82 BRAF (0.42) CA2CA1KMT2AMEN1NPC1
SCHEMBL22010387 0.82 NAPRT (0.41) NOS1CA12CA2CA9CA1
SCHEMBL22010390 0.82 HDAC3 (0.34) NOS1CA2CA1KMT2AMEN1
SCHEMBL22009683 0.82 KMT2A (0.35) NOS1CA12CA2CA9CA1
SCHEMBL22009369 0.81 SRD5A2 (0.41) NOS1KMT2AMEN1ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021229035-A1 UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER FUNDACIÓN PROFESOR NOVOA SANTOS (ES) 2021-11-18 — — WO disclosed
EP-3909577-A1 UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER Fundación Profesor Novoa Santos (ES) 2021-11-17 — — EP disclosed
EP-3653208-A1 COMPOUNDS THAT SELECTIVELY AND EFFECTIVELY INHIBIT HAKAI-MEDIATED UBIQUITINATION, AS ANTI-CANCER DRUGS Fundación Profesor Novoa Santos (ES) 2020-05-20 — — EP disclosed
Send feedback